We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Testing Enables Easier Diagnosis of Mitochondrial Disorders

By LabMedica International staff writers
Posted on 13 Feb 2025

Primary mitochondrial diseases (PMD) are among the most prevalent metabolic genetic disorders, with approximately one in 5,000 people affected by a genetic mitochondrial condition. More...

These diseases are caused by pathogenic variants in the mitochondrial genome (mtDNA) or the nuclear genome (nDNA), which impair mitochondrial function and/or structure. Although there is no cure for PMD, timely treatment can prevent life-threatening complications, making early diagnosis essential. Unfortunately, these disorders are challenging to diagnose because their symptoms overlap with those of other conditions, such as neuromuscular disorders like myasthenia gravis and muscular dystrophy. At present, the diagnosis can only be confirmed through molecular genetic testing, which is resource-intensive. New research, however, may simplify the diagnosis of these severe diseases that disrupt the body’s energy production.

In a new study, researchers at the University of Alberta (Edmonton, Canada) examined 297 individuals with suspected primary mitochondrial disorders to better understand their causes and improve both diagnosis and treatment. Published in Orphanet Journal of Rare Diseases, this study was the first to evaluate mitochondrial DNA testing in urine, an approach that is less expensive and does not require a muscle biopsy. This method offers the potential for quicker and more widespread diagnosis of primary mitochondrial disorders. The study also uncovered differences in how these disorders affect adults and children. Adults are more likely to have a disorder caused by errors in mitochondrial DNA in their cells, while children are more likely to have conditions due to nuclear DNA errors. Additionally, muscle-related issues were found to be more prevalent in adults, whereas brain and developmental problems were more common in children. Recognizing these differences can help doctors choose the appropriate DNA tests and provide tailored treatment and management recommendations for both children and adults.

“With our study, we were hoping to show the differences between primary mitochondrial disorders and non-PMDs and then give specific recommendations for appropriate genetic tests depending on the age of patients,” said principal investigator Saadet Andrews. “We are hoping that it helps guide physicians and clinicians in their thinking about who should receive which genetic investigations, and that it can reduce the time it takes for patients to get a diagnosis.”


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
New
Gold Member
Latex Test
SLE-Latex Test
New
Multilevel Whole Blood Calibrator Set
6PLUS1
New
Biochemistry Analyzer
Chemi+ 8100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The innovative doublet configuration and annular illumination overcome traditional metalens limitations (Photo courtesy of Tao Li and Jiacheng Sun/Nanjing University)

High-Resolution Metalens Doublet Microscope to Enhance Diagnostic Capabilities

Metalenses mark a groundbreaking leap in optical technology. Unlike traditional microscope objectives that rely on curved glass surfaces, metalenses utilize nanoscale structures to manipulate light at... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.